Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

Myths vs. Facts: Getting Dupixent (dupilumab) Covered by UnitedHealthcare in California - Appeals Guide

Answer Box: Getting Dupixent Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Dupixent (dupilumab) with step therapy requirements varying by condition. For atopic dermatitis, you need documented failure of two topical therapies. For asthma, you must show poor control plus eosinophilic phenotype or steroid dependence. If denied, California

Get Elevidys Covered by UnitedHealthcare in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Elevidys Covered by UnitedHealthcare in Michigan UnitedHealthcare requires prior authorization for Elevidys (delandistrogene moxeparvovec-rokl) gene therapy, with mandatory step therapy through corticosteroids first. To get approved: (1) Document failed prednisone/prednisolone trials with doses and duration, (2) Submit genetic DMD confirmation and anti-AAVrh74 antibody testing showing titer

Getting Palynziq Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization and Appeals Guide 2025

Quick Answer: Getting Palynziq Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Palynziq (pegvaliase-pqpz) with mandatory 4-week sapropterin trial first. If denied, Pennsylvania's new Independent External Review program overturns 50% of appeals. Start today: Have your PKU specialist gather blood phenylalanine levels >600 µmol/L,

Denied for Natpara by UnitedHealthcare in New Jersey? Complete 2025 Appeal Guide & Alternative Coverage Options

Answer Box: Natpara was discontinued by Takeda in December 2024, making new prescriptions impossible. If denied coverage for alternative parathyroid hormone treatments like Yorvipath, New Jersey patients can appeal through UnitedHealthcare's internal process (180 days), then New Jersey's Independent Health Care Appeals Program (IHCAP) via Maximus

Renewing Ruconest Approval with UnitedHealthcare in Virginia: 2025 Timeline, Documentation & Appeals Guide

Answer Box: Renewing Ruconest Coverage with UnitedHealthcare in Virginia UnitedHealthcare requires 12-month reauthorization for Ruconest with documented attack frequency over the past year. Start renewal 30-45 days before expiration. Submit attack logs, specialist notes, and current lab values through the UHC Provider Portal. If denied, appeal within 180 days, then

How to Get iLink® Corneal Cross-Linking Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting UnitedHealthcare Coverage for iLink® in New York UnitedHealthcare requires prior authorization for iLink® corneal cross-linking in New York. Fastest path to approval: Have your ophthalmologist submit PA through the UnitedHealthcare Provider Portal with serial corneal topography showing ≥1.0 diopter progression over 12-24 months, documented failed conservative

Myths vs. Facts: Getting Vyondys 53 (golodirsen) Covered by UnitedHealthcare in New York

Answer Box: Getting Vyondys 53 Covered by UnitedHealthcare in New York Vyondys 53 (golodirsen) requires prior authorization from UnitedHealthcare and is billed as a medical benefit under J1429. Key requirements: confirmed exon 53-amenable DMD mutation via genetic testing, ambulatory status (6MWT ≥300m), and neuromuscular specialist involvement. If denied, New York

How to Get Zolgensma Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Zolgensma Approved by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Zolgensma with strict criteria: confirmed SMN1 mutations, age under 2 years, anti-AAV9 antibody titers ≤1:50, and administration at certified infusion centers. Start by submitting genetic testing results and AAV9 titers through the UHC provider portal.

Renewing Rinvoq (Upadacitinib) Approval with UnitedHealthcare in New York: Timeline, Documentation & Appeal Options

Answer Box: UnitedHealthcare approves Rinvoq renewals for 12 months with documented clinical response and safety labs. Start renewal 45-60 days before expiration by scheduling response assessment, gathering current labs (CBC, liver function, lipids), and submitting via OptumRx portal. If denied, file internal appeal within 180 days, then external review through

How to Get Alecensa (Alectinib) Covered by UnitedHealthcare in Michigan: Complete Prior Authorization Guide

Answer Box: Getting Alecensa Covered by UnitedHealthcare in Michigan UnitedHealthcare requires prior authorization for Alecensa (alectinib) in Michigan for ALK-positive NSCLC, with no step therapy requirements. Submit PA through the UnitedHealthcare Provider Portal with ALK test results, oncologist prescription, and diagnosis documentation. If denied, file internal appeal within 30 days,